Dr. Dennis Salmon, professor and chief of hematology/oncology at UCLA and UCLA IUO physician-scientist, has been awarded the 2019 Lasker-DeBakey Clinical Medical Research Award for the groundbreaking development of breast cancer drug Herceptin (trastuzumab), a lifesaving therapy for women with HER2-positive breast cancer. The award, to be presented on Sept. 20, is widely regarded as America’s top biomedical research prize. UCLA Newsroom >
An international team of researchers led by Paul Boutros, PhD, have created a new way to accurately estimate how fast an individual cancer is evolving using open-source software, which makes big data sets easily accessible to the public. JCCC news release >
Dr. Brian Shuch, associate professor of urology and Dr. Sandy Liu, clinical instructor in medicine, hematology-oncology, present an overview of The UCLA Kidney Cancer Program that spans across multiple departments to bring the very best of UCLA to fight a challenging disease.
REGISTER TODAY! The 45th Annual UCLA State-of-the-Art Urology Conference will be held March 6 - 8, 2020 at the The Ritz-Carlton in Marina del Rey. This CME live course explores the most challenging management problems facing the practicing urologist.
For information and registration >
Targeted Treatment of Metastatic Castration-Resistant Prostate Cancer
The purpose of this study is to see if the study drug, Trametinib, is safe and effective for the treatment of metastatic castration-resistant prostate cancer. View Clinical Trial >
UCLA researcher uses big data to help optimize cancer treatment. How can datasets help reveal new ways to treat cancer? UCLA Jonsson Cancer Center's Paul Boutros shares how his lab is working in collaboration with research centers around the world to use big data to help develop new ways to fight this disease.
Story on newsroom.ucla.edu >